NYSE:CHE | Jotup

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024

Retrieved on:

Tuesday, May 7, 2024

Commercial Building & Real Estate, Construction & Property, Other Retail, Building Systems, Managed Care, General Health, Health, Other Construction & Property, Retail, Residential Building & Real Estate, VITAS, PDT, Wynn Las Vegas, Bank, VITAS Healthcare, Roto-Rooter, Conference, Risk

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the Encore at the Wynn Las Vegas.

Key Points:

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the Encore at the Wynn Las Vegas.
The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.

Chemed Reports First-Quarter 2024 Results

Retrieved on:

Wednesday, April 24, 2024

There was no material impact on financial results for the quarter-ended March 31, 2024 as a result of the Retention Program.

Key Points:

There was no material impact on financial results for the quarter-ended March 31, 2024 as a result of the Retention Program.
As of March 31, 2024, Chemed had total cash and cash equivalents of $313.4 million and no current or long-term debt.
Management anticipates providing updated 2024 earnings guidance and related subsidiary operating metrics as part of the June 30, 2024 earnings press release.
As previously disclosed, Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday April 25, 2024, to discuss the company's quarterly results and to provide an update on its business.

VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama

Retrieved on:

Wednesday, April 17, 2024

Residential Building & Real Estate, Other Retail, Commercial Building & Real Estate, Construction & Property, Managed Care, Health, General Health, Building Systems, Retail, Hospitals, Other Construction & Property, Risk, Roto-Rooter, VITAS, VITAS Healthcare, Community service, Covenant Health

VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care (“Covenant”) for an aggregate purchase price of $85 million.

Key Points:

VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care (“Covenant”) for an aggregate purchase price of $85 million.
Covenant’s hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama.
The transaction, which was announced on March 13, 2024, closed effective April 17, 2024.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.

Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25

Retrieved on:

Monday, April 1, 2024

Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 25, 2024, to discuss the company's quarterly results and to provide an update on its business.

Key Points:

Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 25, 2024, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/as75yrfc .
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call.
Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.

VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

Retrieved on:

Wednesday, March 13, 2024

Covenant’s hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama.

Key Points:

Covenant’s hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama.
Nick Westfall, Chairman and CEO of VITAS Healthcare, stated, “Covenant Care has a 44-year history of providing high-quality, patient-centered care across communities in Florida and Alabama.
We are excited to welcome the Covenant Care team members who decide to join our VITAS family as we collectively move forward with making a difference in all the communities we have the privilege of serving.
VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference

Retrieved on:

Friday, March 8, 2024

Commercial Building & Real Estate, Construction & Property, Other Retail, Building Systems, Managed Care, General Health, Health, Other Construction & Property, Retail, Residential Building & Real Estate, Roto-Rooter, VITAS Healthcare, VITAS, Risk, Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024, at approximately 12:00 p.m. (ET).

Key Points:

Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024, at approximately 12:00 p.m. (ET).
The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.

Chemed Reports Fourth-Quarter 2023 Results

Retrieved on:

Tuesday, February 27, 2024

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2023, versus the comparable prior-year period.

Key Points:

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2023, versus the comparable prior-year period.
Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results.
As of December 31, 2023, Chemed had total cash and cash equivalents of $264.0 million and no current or long-term debt.
Chemed’s 2023 adjusted earnings per diluted share was $20.30, including $1.04 per share for costs associated with the 2023 portion of the Retention Program.

Chemed Corporation Declares Quarterly Dividend of 40 Cents

Retrieved on:

Friday, February 16, 2024

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on March 15, 2024, to shareholders of record as of February 26, 2024.

Key Points:

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on March 15, 2024, to shareholders of record as of February 26, 2024.
This represents the 211th consecutive quarterly dividend paid by Chemed in its 52 years as a public company.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.

Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28

Retrieved on:

Wednesday, February 14, 2024

Commercial Building & Real Estate, Construction & Property, Other Retail, Building Systems, Managed Care, General Health, Health, Other Construction & Property, Retail, Residential Building & Real Estate, Roto-Rooter, VITAS Healthcare, VITAS, Webcast, Risk, Cryptocurrency

Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, February 28, 2024, to discuss the company's quarterly results and to provide an update on its business.

Key Points:

Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, February 28, 2024, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/586r6wmh .
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call.
Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.

Chemed Corporation to Present at the 42nd Annual JPMorgan Healthcare Conference

Retrieved on:

Friday, December 29, 2023

Commercial Building & Real Estate, Construction & Property, Other Retail, Managed Care, Health, Building Systems, Retail, Residential Building & Real Estate, PST, VITAS Healthcare, Conference, Roto-Rooter, VITAS, Risk

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 42nd Annual JPMorgan Healthcare Conference on Monday, January 8, 2024, at approximately 3:00 p.m. PST at the Westin St. Francis Hotel in San Francisco, CA.

Key Points:

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 42nd Annual JPMorgan Healthcare Conference on Monday, January 8, 2024, at approximately 3:00 p.m. PST at the Westin St. Francis Hotel in San Francisco, CA.
The presentation will be webcast live and can be accessed through the Chemed website at www.chemed.com (Investor Relations).
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( www.chemed.com ) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.